Paclitaxel plus bevacizumab for metastatic breast cancer.
Haines
Ian E
IE
Miklos
George L Gabor
GL
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D018450:Disease Progression; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D011788:Quality of Life; D016019:Survival Analysis
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D017239:Paclitaxel